New injection aims to wake muscles after surgery
NCT ID NCT07195604
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a single dose of HRS-2162 injection in 64 healthy volunteers to see if it is safe and how the body processes it. The drug is designed to reverse neuromuscular blockade, a temporary muscle paralysis used during surgery. Researchers will monitor side effects and measure drug levels in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HRS-2162 injection
- What this could lead to
- If successful, this could lead to a new option for quickly reversing muscle paralysis after surgery or in emergency settings.
- What could go wrong
- This is an early Phase 1 trial in only 64 healthy people, so safety and effectiveness are not yet proven. It may not work as hoped or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSAL OF NEUROMUSCULAR BLOCKADE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.